Skip to search formSkip to main contentSkip to account menu

NSC 100880

Known as: NSC-100880 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Camptothecin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A Phase II Study of CPT-11 , a New Derivative of Camptothecin , for Previously Untreated Non
Barilero, et al., Simultaneous determination of the camp tothecin analogue CPT-11 and its active metabolite SN-38 by high… 
2006
2006
Cell Cycle Phase Specificity of Antitumor Agentsl
SUMMARY The sensitivity to drugs of synchronous and asynchronous populations of DON cells was studied. Agents that were cytotoxic… 
1974
1974
Reusable autoclavable silicone rubber dish for insect dissection
During a disease-diagnosis study which involved a large number of gypsy moth larvae, Porthetria dispar (L.),it became necessary… 
1973
1973
Pharmacologic studies of camptothecin (NSC-100880): distribution, plasma protein binding, and biliary excretion.
Highly Cited
1972
Highly Cited
1972
Treatment of malignant melanoma with camptothecin (NSC-100880).
1969
1969
Studies of the physiological disposition of the antitumor agent, camp- tothecin sodium (nsc 100880) in rodents. Abstr.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)